What information is included in an Investigational New Drug application?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

An Investigational New Drug (IND) application is a required document submitted to the U.S. FDA by pharmaceutical firms seeking approval to begin human clinical trials for a new drug.1

To ensure the safety and ethical treatment of human subjects, an IND application must include the following information:

  • Chemical and Dosage Details: Information regarding the chemical makeup of the drug and its specific dosage form.1
  • Preclinical Data: Summaries of animal pharmacology and toxicology studies.1
  • Pharmacokinetic Data: Information regarding how the drug moves through the body.1
  • Previous Investigations: Details concerning any prior clinical investigations of the drug.1
  • Study Protocols: Descriptions of the trials to be conducted, including Phase 1 protocols, which outline the initial use of the drug in humans to assess safety and dosage profiles.1

This application is a critical step in the development process, ensuring that research is conducted with scientific rigor before a drug is considered for broader marketing approval.1